ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 44 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20 | +300.0% | 16,000 | 0.0% | 0.00% | +300.0% |
| Q2 2023 | $5 | -28.6% | 16,000 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $7 | -12.5% | 16,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $8 | -99.9% | 16,000 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $12,000 | -33.3% | 16,000 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $18,000 | -45.5% | 16,000 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $33,000 | -61.2% | 16,000 | 0.0% | 0.01% | -64.7% |
| Q2 2021 | $85,000 | +14.9% | 16,000 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $74,000 | +39.6% | 16,000 | 0.0% | 0.02% | +41.7% |
| Q4 2020 | $53,000 | – | 16,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 2,679,457 | $20,257,000 | 0.73% |
| Portolan Capital Management | 777,293 | $5,876,000 | 0.66% |
| CAMPBELL CAPITAL MANAGEMENT INC | 110,451 | $835,000 | 0.62% |
| ZEKE CAPITAL ADVISORS, LLC | 402,212 | $3,041,000 | 0.27% |
| Leap Investments LP | 46,084 | $348,000 | 0.17% |
| Bernardo Wealth Planning LLC | 26,419 | $199,000 | 0.14% |
| Claraphi Advisory Network, LLC | 14,744 | $111,000 | 0.07% |
| Sterling Investment Advisors, Ltd. | 11,000 | $83,000 | 0.04% |
| A.R.T. Advisors, LLC | 81,372 | $615,000 | 0.03% |
| Mirae Asset Global Investments Co., Ltd. | 544,408 | $4,116,000 | 0.03% |